TB-500 Dose: What Research Does and Does Not Establish
There is no established regulator-approved human dosing schedule for TB-500 as sold in experimental peptide markets.
Research information only. This guide is educational, not medical advice or an injection, mixing or dosing protocol. Unapproved research substances are not established as safe for human use.
Is there an approved TB-500 dose?
There is no established regulator-approved human dosing schedule for TB-500 as sold in experimental peptide markets.
Is TB-500 the same as thymosin beta-4?
Names are often used loosely online, but the identity of a marketed product and the molecule studied in research must be checked carefully.
Can animal-study doses be used in people?
No. Species differences, formulation, exposure and safety uncertainties mean animal-study dosing cannot establish a safe human regimen.
Why are people interested in TB-500?
Preclinical work on tissue biology has generated interest, but claims about recovery and performance in humans remain insufficiently supported.
Explore related research
For the underlying science, consult peer-reviewed literature and official clinical-trial and medicine-regulator records. Avoid relying on marketing claims or animal results as proof of human benefit.